Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Surprise Failure for Intra-Cellular Therapies’ Schizophrenia Drug Sends Shares Tumbling

Scientist

Related Content

Intra-Cellular Surges On First Phase III Schizophrenia Data

Sep 17 2015

Related Companies

Intra-Cellular Therapies, Inc.

Otsuka Holdings Co., Ltd.

Bristol Myers Squibb Company

H. Lundbeck A/S

Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd.

Additional Topics

Research & Development Clinical Trials Neurology BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window